沉默信号转导和转录激活因子3 (STAT3)和使用抗程序性细胞死亡配体1 (PD-L1)抗体诱导免疫反应和抗肿瘤活性。

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research Pub Date : 2023-07-20 DOI:10.12659/MSM.941845

Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi

{"title":"沉默信号转导和转录激活因子3 (STAT3)和使用抗程序性细胞死亡配体1 (PD-L1)抗体诱导免疫反应和抗肿瘤活性。","authors":"Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi","doi":"10.12659/MSM.941845","DOIUrl":null,"url":null,"abstract":"It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.","PeriodicalId":18276,"journal":{"name":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research","volume":"29 ","pages":"e941845"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/88/medscimonit-29-e941845.PMC10368140.pdf","citationCount":"0","resultStr":"{\"title\":\"Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.\",\"authors\":\"Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi\",\"doi\":\"10.12659/MSM.941845\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.\",\"PeriodicalId\":18276,\"journal\":{\"name\":\"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research\",\"volume\":\"29 \",\"pages\":\"e941845\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/41/88/medscimonit-29-e941845.PMC10368140.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12659/MSM.941845\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Science Monitor : International Medical Journal of Experimental and Clinical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12659/MSM.941845","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

作者提请我们注意，图5A和图6A包含错误。图5A和图6A的正确版本如下:修正后的数字不会改变研究的总体结果。参考文献:王嘉兴，黄发坤，蒋彩云，池攀。沉默转录信号转导和激活因子3 (STAT3)和使用抗程序性细胞死亡配体1 (PD-L1)抗体诱导免疫应答和抗肿瘤活性医学监测，2020;26: e915854。DOI: 10.12659 / MSM.915854。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.

查看原文本刊更多论文

Errate: Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity.

It was brought to our attention by the authors that Figures 5A and 6A contained errors. The correct version of Figures 5A and 6A are provided below. The corrected figures do not change the overall findings of the study. Reference: Jiaxing Wang, Fakun Huang, Caiyun Jiang, Pan Chi. Silencing Signal Transducer and Activator of Transcription 3 (STAT3) and Use of Anti-Programmed Cell Death-Ligand 1 (PD-L1) Antibody Induces Immune Response and Anti-Tumor Activity. Med Sci Monit, 2020; 26: e915854. DOI: 10.12659/MSM.915854.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Medical Science Monitor : International Medical Journal of Experimental and Clinical Research

自引率

0.00%

发文量